Data / Form D filings / PROLACTA BIOSCIENCE INC
PROLACTA BIOSCIENCE INC: Form D filings
PROLACTA BIOSCIENCE INC, a biotechnology company in Duarte, CA, filed 4 Form D notices with the SEC between 2011 and 2018. The latest, on May 14, 2018, reports $8.9 million sold of a $8.9 million offering to 11 investors.
Find out what PROLACTA BIOSCIENCE INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1800 Highland Ave, Duarte, CA, 91010
- Phone
- (626) 599-9260
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1294955
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 14, 2018 | New notice | $8,908,625 | $8,908,625 | $0 | 11 | May 10, 2018 | sec.gov |
| Dec 9, 2016 | New notice | $34,999,997 | $34,999,997 | $0 | 4 | Nov 29, 2016 | sec.gov |
| Nov 2, 2011 | New notice | $15,000,000 | $15,000,000 | $0 | 2 | Oct 27, 2011 | sec.gov |
| Aug 9, 2011 | New notice | $5,783,892 | $5,783,892 | $0 | 20 | Jun 17, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| John Shields | Executive Officer | |
| David Brailer | Director | |
| Mark Hannon | Executive Officer | |
| Victoria Niklas | Executive Officer | |
| Ernie Strapazon | Director | |
| Frank Foster | Director | |
| John Bacich Jr. | Director | |
| David Dreyer | Executive Officer | |
| Vincent Gaspar | Executive Officer | |
| Alan Kofsky | Executive Officer | |
| Martin Sutter | Director | |
| Scott Eaker | Executive Officer | |
| Scott Elster | Executive Officer, Director | |
| Joseph Fournell | Executive Officer | |
| Martin Lee | Executive Officer | |
| Dan Janney | Director | |
| Sally Crawford | Director | |
| Alyson Fuller | Executive Officer |
Other biotechnology companies in California that filed recently
- CARI Health, Inc. $280,000 · Nov 6, 2026
- Ausel, Inc. $120,000 · Nov 4, 2026
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
Every Form D from the week of May 14, 2018 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what PROLACTA BIOSCIENCE INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.